The development of a rational prescribing pattern for antiplatelet drugs in patients with ischemic stroke at Inburi Hospital
Article Sidebar
Main Article Content
Abstract
Ischemic stroke is a significant public health problem both in Thailand and worldwide, characterized by high incidence and mortality rates that substantial impacts on quality of life and healthcare costs. This study aimed to investigate the issues and current practices of antiplatelet prescribing, and to develop a model to promote rational antiplatelet use in patients with ischemic stroke at Inburi Hospital from 1 June 2023 to 31 March 2024. The research comprised four phases: (1) problem analysis and needs assessment through stakeholder interviews and literature review; (2) design and development of a rational antiplatelet prescribing model; (3) implementation and evaluation of the developed model; and (4) assessment and refinement of the model for suitability and readiness for broader application. The results demonstrated that the developed model significantly improved rational antiplatelet prescribing, increasing appropriateness from 29.17% to 95.92% (p < 0.001), reducing medication error rates by 25.93%, increasing physician acceptance of pharmacist recommendations to 90.91%, and achieving the highest level of staff satisfaction. Based on these findings, it is recommended to expand the implementation of this model to other problematic disease groups within the hospital to establish a quality patient care system.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
World Stroke Organization. Annual report 2021 [Internet]. 2021 [cited 2024 Oct 30]. Available from: https://www.world-stroke.org/assets/downloads/Annual_Report_2021_online_latest.pdf
Public Relations Division, Office of the Permanent Secretary, Ministry of Public Health. MOPH news [Internet]. 2020 [cited 2024 Oct 30]. Available from: http://pr.moph.go.th/iprg/include/admin_hotnew/show_hotnew.php?idHot_new=86419 (in Thai)
Suwanwela NC. Stroke epidemiology in Thailand. J Stroke. 2014;16(1):1-7.
Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35-41.
Tuntirithisak T. Treatment guidelines for ischemic stroke for physicians: clinical practice guidelines for ischemic stroke. Bangkok: Neurological Institute of Thailand; 2012. (in Thai)
Wang Y, Wang Y, Zhao X, Liu L, Wang D, Wang C, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013;369(1):11-9.
Johnston SC, Easton JD, Farrant M, Barsan W, Conwit RA, Elm JJ, et al. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med. 2018;379(3):215-25.
Abdul Rahman L, Turan TN, Cotsonis G, Almallouhi E, Holmstedt CA, Chimowitz MI. Dual antiplatelet therapy beyond 90 days in symptomatic intracranial stenosis in the SAMMPRIS trial. J Stroke Cerebrovasc Dis. 2020;29 (12):105254.
Bhatia K, Jain V, Aggarwal D, Vaduganathan M, Arora S, Hussain Z, et al. Dual Antiplatelet Therapy Versus Aspirin in Patients With Stroke or Transient Ischemic Attack: Meta-Analysis of Randomized Controlled Trials. Stroke. 2021 Jun;52(6):e217-e223.
Bureau of Policy and Strategy, Ministry of Public Health. Mortality rate of patients with ischemic stroke (I63) [Internet]. 2023 [cited 2024 Oct 22]. Available from: https://hdc.moph.go.th/center/public/standard-report-detail/fc4ef4b0a87cd045a5d9defa44f15de8 (in Thai)
Agency for Healthcare Research and Quality. Computerized clinical decision support to prevent medication errors and adverse drug events: rapid review. Rockville (MD): Agency for Healthcare Research and Quality (US); 2024.
Neurological Institute of Thailand, Department of Medical Services, Ministry of Public Health. stroke (paralysis, hemiparesis) handbook for the public. 3rd ed. Bangkok: Neurological Institute of Thailand; 2013. (in Thai)
Sibmoo N. Pharmacology: principles and exercises. Bangkok: Holistic Publishing; 2009. (in Thai)
Krejcie RV, Morgan DW. Determining sample size for research activities. Educ Psychol Meas.1970; 30(3):607–10.
Klaypaksi A, Polnok A. Effect of developed computerized clinical decision support system on medication use in patients with renal impairment. Thai J Pharm Prac. 2020;12(2):437-51. (in Thai)
Lee TL, Chang YM, Sung PS. Clinical updates on antiplatelet therapy for secondary prevention in acute ischemic stroke. Acta Neurol Taiwan. 2023;32(3): 138-44.
Meschia JF, Bushnell C, Boden-Albala B, Braun LT, Bravata DM, Chaturvedi S, et al. Guidelines for the primary prevention of stroke: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(12):3754-832.
Ibáñez-Garcia S, Rodriguez-Gonzalez C, Escudero-Vilaplana V, Martin-Barbero ML, Marzal-Alfaro B, De la Rosa-Triviño JL, et al. Development and evaluation of a clinical decision support system to improve medication safety. Appl Clin Inform. 2019;10(3):513-20.
Chanachai P, Pinbutr T. Effectiveness of nursing practice guidelines in stroke patients, emergency and forensic nursing division, Sopisai Hospital [Internet]. 2024 [cited 2024 Nov 2]. Available from: https://bkpho.moph.go.th/ssjweb/bkresearch/require/files/post-doc/20240423104823.pdf (in Thai)
Supapaan T, Amornphetsathaporn J, Jansiri N, Kam-Ing N, Janthapim P, Chompoopuen P, et al. Narrative literature review: outcome measurement of hospital pharmaceutical care in Thailand. Isan J Pharm Sci. 2021;17(4):1-29. (in Thai)
